Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats-Reference-Cited by-同舟云学术

Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats

Published:2006-01 Issue:1 Volume:96 Page:88-94
ISSN:0007-0912
Container-title:British Journal of Anaesthesia
language:en
Short-container-title:British Journal of Anaesthesia

Author:

Kakinohana M,Nakamura S,Fuchigami T,Davison K.J.,Marsala M,Sugahara K

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine

Link

http://academic.oup.com/bja/article-pdf/96/1/88/707718/aei285.pdf

Reference22 articles.

1. High-dose intrathecal morphine for thoracoabdominal aneurysm repair;Chaney;J Cardiothorac Vasc Anesth,1996

2. Beta-endorphine in experimental canine spinal ischaemia;De Riu;Stroke,1989

3. Naloxone in experimental spinal cord ischaemia: dose-response studies;Faden;Eur J Pharmacol,1984

4. Neuraxial morphine may trigger transient spasticity after a noninjurious interval of spinal cord ischaemia: a clinical and experimental study;Kakinohana;Anesthesiology,2003

5. Intrathecal administration of morphine, but not small dose, induced spastic paraparesis after a noninjurious interval of aortic occlusion in rats;Kakinohana;Anesth Analg,2003

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spinal Cord Disorders;Obstetric Anesthesia and Uncommon Disorders;2024-02-01

2. Intrathecal Agents Used for Spasticity;Neuraxial Therapeutics;2023

3. Intrathecal morphine exacerbates paresis with increasing muscle tone of hindlimbs in rats with mild thoracic spinal cord injury but without damage of lumbar α-motoneurons;PLOS ONE;2022-08-15

4. 2-PMAP Ameliorates Cerebral Vasospasm and Brain Injury after Subarachnoid Hemorrhage by Regulating Neuro-Inflammation in Rats;Cells;2022-01-12

5. Sialorphin Potentiates Effects of [Met5]Enkephalin without Toxicity by Action other than Peptidase Inhibition;Journal of Pharmacology and Experimental Therapeutics;2020-08-05